{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:24:01Z","timestamp":1790029441806,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021867","name":"Government of Canada Department of Foreign Affairs Trade and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biologicals.2025.101826","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T13:47:48Z","timestamp":1742737668000},"page":"101826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Multiple factors shape technology transfer for the development and manufacture of vaccines in Latin America and the Caribbean"],"prefix":"10.1016","volume":"90","author":[{"given":"Nelson","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de los \u00c1ngeles","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s A.","family":"Pippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Rius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Couve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2025.101826_bib1","unstructured":"Statista: https:\/\/es.statista.com\/estadisticas\/1258801\/porcentaje-y-numero-vacunados-contra-covid-19-en-latinoamerica-por-pais\/, accessed November 14, 2024."},{"key":"10.1016\/j.biologicals.2025.101826_bib2","series-title":"COVID-19 and vaccination in Latin America and the caribbean: challenges, needs and opportunities","article-title":"Chapter III: development and production of covid-19 vaccines in Latin America and the caribbean","author":"Velez","year":"2021"},{"key":"10.1016\/j.biologicals.2025.101826_bib3","series-title":"COVID-19 and vaccination in Latin America and the caribbean: challenges, needs and opportunities","article-title":"Chapter II: access to covid-19 vaccines in the region","author":"Velez","year":"2021"},{"key":"10.1016\/j.biologicals.2025.101826_bib4","series-title":"59th directing council, 3rd session of the regional committee of WHO for the Americas","article-title":"Increasing production capacity for essential medicines and health technologies","year":"2021"},{"key":"10.1016\/j.biologicals.2025.101826_bib5","series-title":"Increasing production capacity for essential medicines and health technologies","year":"2021"},{"key":"10.1016\/j.biologicals.2025.101826_bib6","series-title":"Increasing access to vaccines through technology transfer and local production","article-title":"Chapter 1., background and context","year":"2011"},{"key":"10.1016\/j.biologicals.2025.101826_bib8","author":"Correa"},{"key":"10.1016\/j.biologicals.2025.101826_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41587-021-00912-9","article-title":"A network analysis of COVID-19 mRNA vaccine patents","volume":"39","author":"Gaviria","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biologicals.2025.101826_bib10","author":"Vargas"},{"key":"10.1016\/j.biologicals.2025.101826_bib11","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing \u2013 an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2025.101826_bib12","series-title":"Regulatory system strengthening in the Americas: lessons learned from the national regulatory Authorities of regional reference","year":"2022"},{"key":"10.1016\/j.biologicals.2025.101826_bib13","series-title":"Ninth conference of the Pan American network for drug regulatory harmonization (PANDRH)","article-title":"Regulatory reliance principles: concept note and recommendations","year":"2019"},{"key":"10.1016\/j.biologicals.2025.101826_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2021.10","article-title":"Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries","volume":"45","author":"Dur\u00e1n","year":"2021","journal-title":"Rev Panam Salud P\u00fablic"},{"key":"10.1016\/j.biologicals.2025.101826_bib16","author":"Vargas"},{"key":"10.1016\/j.biologicals.2025.101826_bib25","series-title":"La cooperaci\u00f3n Sur-Sur en Am\u00e9rica Latina y el Caribe: Balance de una d\u00e9cada (2008-2018)","article-title":"La cooperaci\u00f3n Sur-Sur de Cuba: autoafirmaci\u00f3n y solidaridad internacional","author":"Ojeda-Medina","year":"2019"}],"updated-by":[{"DOI":"10.1016\/j.biologicals.2025.101830","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510562500017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510562500017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:50:29Z","timestamp":1762354229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510562500017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"alternative-id":["S104510562500017X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2025.101826","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple factors shape technology transfer for the development and manufacture of vaccines in Latin America and the Caribbean","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2025.101826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}],"article-number":"101826"}}